49.75p+0.75 (+1.53%)28 Mar 2024, 16:35
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Avacta Group PLC Fundamentals

Company NameAvacta Group PLCLast Updated2024-03-28
IndustryBiotechnologySectorHealthcare
Shares in Issue350.512 mMarket Cap£174.38 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.15EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.2547Debt Equity Ratio0.2173
Asset Equity Ratio3.8591Cash Equity Ratio1.1421
Quick Ratio0.5732Current Ratio0.71
Price To Book Value7.6687ROCE0

Avacta Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Avacta Group PLC Company Financials

Assets20222021
Tangible Assets£7.80 m£4.34 m
Intangible Assets£26.32 m£7.92 m
Investments£2.98 m0
Total Fixed Assets£37.10 m£12.27 m
Stocks£1.68 m£189,000.00
Debtors£3.72 m£1.74 m
Cash & Equivalents£41.78 m£26.19 m
Other Assets00
Total Assets£92.65 m£47.00 m
Liabilities20222021
Creditors within 1 year£67.61 m£4.37 m
Creditors after 1 year£6.60 m£1.41 m
Other Liabilities0£346,000.00
Total Liabilities£74.21 m£5.78 m
Net assets£18.44 m£41.22 m
Equity20222021
Called up share capital£26.61 m£25.39 m
Share Premium£62.18 m£54.53 m
Profit / Loss-£41.64 m-£29.19 m
Other Equity£18.44 m£41.22 m
Preference & Minorities00
Total Capital Employed£18.44 m£41.22 m
Ratios20222021
Debt Ratio£0.17£0.03
Debt-to-Equity£0.20£0.03
Assets / Equity3.85913.8591
Cash / Equity1.14211.1421
EPS-£0.12-£0.11
Cash Flow20222021
Cash from operating activities-£16.43 m-£20.51 m
Cashflow before financing£40.47 m-£20.27 m
Increase in Cash£15.43 m-£1.57 m
Income20222021
Turnover£9.65 m£2.94 m
Cost of sales£2.41 m£924,000.00
Gross Profit£7.24 m£2.02 m
Operating Profit-£32.65 m-£29.08 m
Pre-Tax profit-£41.64 m-£29.19 m

Avacta Group PLC Company Background

SectorHealthcare
ActivitiesAvacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.
Latest Interim Date28 Sep 2023
Latest Fiscal Year End Date25 Apr 2023

Avacta Group PLC Directors

AppointedNamePosition
2023-06-02Dr. Trevor John Nicholls Non-Executive Director
2011-12-15Dr. Barry PorterNon-Executive Director
2015-01-23Dr. Gwynfor Owen HumphreysNon-Executive Director
2024-03-04Professor Dr. David Alastair MacLaughlin Smith Executive Director,Chief Executive
2019-01-21Mr. Alan John AubreyNon-Executive Director
2023-09-29Mr. Tony Peter GardinerExecutive Director,Chief Financial Officer and Company Secretary
2016-12-02Mr. Timothy James SykesExecutive Director,Chief Financial Officer and Co Secretary
2014-01-24Professor Anthony William Robards, OBENon-Executive Director
2017-12-05Mr. Craig SlaterExecutive Director,Chief Operating Officer
2005-04-30Mr. Kui Man YeungNon-Executive Director
2011-08-09Dr. Simon Webster, PhDExecutive Director,Chief Scientific Officer
2011-08-09Dr. Kurt Justin Baldwin, M.Sc.,PhDExecutive Director,Chief Technology Officer
2011-08-09Mr. Russell Winston HodgettsExecutive Director,Chief Operating Officer
2024-03-04Mr. Shaun Edward ChiltonNon-Executive Director
2018-03-29Dr. Michael Scott AlbinNon-Executive Director
2019-11-04Dr. Samuel Cameron Williams Non-Executive Director
2021-03-25Dr. Michael John OwenNon-Executive Director,Senior Independent Director
2024-03-04Dr. Eliot Richard Forster, M.B.A.,PhDNon-Executive Director,Chairman
2021-05-25Mr. Paul Andrew Fry Non-Executive Director
2024-03-04Dr. Christina Marie CoughlinExecutive Director,Head of Research and Development

Avacta Group PLC Contact Details

Company NameAvacta Group PLC
AddressUnit 20, Ash Way, Thorp Arch Estate, Wetherby, LS23 7FA
Telephone+44 1904217070
Websitehttps://www.avacta.com

Avacta Group PLC Advisors

StockbrokerWG Partners
StockbrokerFinnCap
Phone+44 2072200500
Fax+44 2076001659
Nominated AdviserFinnCap
Phone+44 2072200500
Fax+44 2076001659
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
AuditorKPMG
Phone+44 1132313000
Fax+44 1132313200
SolicitorWalker Morris
Phone+44 1132832500
Fax+44 1132459412
BankNational Westminster Bank PLC
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342